Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 5/2018

15.02.2018 | Original Article – Cancer Research

MID1–PP2A complex functions as new insights in human lung adenocarcinoma

verfasst von: Lin Zhang, Junyao Li, Xuejiao Lv, Tingting Guo, Wei Li, Jie Zhang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

MID1 is an E3 ubiquitin ligase that was first found in Opitz G/BBB syndrome, but there has been little research into its role in lung diseases. We have found an accumulating evidence that indicates the MID1–PP2A complex plays a role in asthma and contributes to inflammation, but its roles in lung adenocarcinoma are unclear. This study aimed at evaluating the function of MID1–PP2A complex in human lung adenocarcinoma.

Methods

We used western blot, ELISA and real-time quantitative PCR to detect the protein and mRNA levels of MID1 and PP2A in A549, H1975, and H1650 lung adenocarcinoma cell lines compared with the human bronchial epithelial cell line BEAS-2B. Additionally, we used IHC, ELISA and real-time quantitative PCR to dectect MID1 and PP2A levels in 30-paired lung adenocarcinoma tissues. We also detected apoptosis, proliferation and cell cycle-related protein expression after silencing MID1 and activing PP2A.

Results

Our data show that MID1 was significantly upregulated in 30-paired lung adenocarcinoma tissues, and in A549, H1975 and H1650 cell lines compared with BEAS-2B. PP2A showed the opposite results. Furthermore, both upregulated MID1 and downregulated PP2A were correlated with age, but not sex, TNM stage or smoking history. In vitro experiments showed that PP2A was upregulated in lung adenocarcinoma cell lines that were transfected with MID1-siRNA, suggesting MID1 negatively regulates PP2A in lung adenocarcinoma. We also found that silencing MID1 expression or activating PP2A induced apoptosis, proliferation and cell cycle arrest.

Conclusions

We demonstrated that the MID1–PP2A complex plays an important role in lung adenocarcinoma, influencing cell cycle progression, proliferation and apoptosis. Our findings showed a novel molecular mechanism of lung tumorigenesis that may provide new insights for anti-tumor therapies.
Literatur
Zurück zum Zitat Bishop JM (1991) Mol Themes Oncog Cell 64:235–248 Bishop JM (1991) Mol Themes Oncog Cell 64:235–248
Zurück zum Zitat Kloeker S et al. (2003) Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein Protein Expr Purif 31:19–33CrossRefPubMed Kloeker S et al. (2003) Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein Protein Expr Purif 31:19–33CrossRefPubMed
Zurück zum Zitat Li J, Yang M, Li P, Su Z, Gao P, Zhang J (2014) Idiopathic pulmonary fibrosis will increase the risk of lung cancer. Chinese Med J 127:3142–3149 Li J, Yang M, Li P, Su Z, Gao P, Zhang J (2014) Idiopathic pulmonary fibrosis will increase the risk of lung cancer. Chinese Med J 127:3142–3149
Zurück zum Zitat Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075–3079PubMed Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075–3079PubMed
Zurück zum Zitat Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Prolif 36:131–149CrossRefPubMed Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Prolif 36:131–149CrossRefPubMed
Zurück zum Zitat Winter J, Basilicata MF, Stemmler MP, Krauss S (2016) The MID1 protein is a central player during development and in disease. Frontiers Biosci 21:664–682CrossRef Winter J, Basilicata MF, Stemmler MP, Krauss S (2016) The MID1 protein is a central player during development and in disease. Frontiers Biosci 21:664–682CrossRef
Metadaten
Titel
MID1–PP2A complex functions as new insights in human lung adenocarcinoma
verfasst von
Lin Zhang
Junyao Li
Xuejiao Lv
Tingting Guo
Wei Li
Jie Zhang
Publikationsdatum
15.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2018
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-018-2601-0

Weitere Artikel der Ausgabe 5/2018

Journal of Cancer Research and Clinical Oncology 5/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.